Gilead Elated as the FDA OKs New Blockbuster HIV Pill Biktarvy Post author:Sam Post published:February 7, 2018 Post category:BioPharma The FDA approved Gilead’s triple combination treatment for HIV, Biktarvy. Source: BioSpace You Might Also Like Shire Plans to Hire in 2018 for its Georgia Manufacturing Site December 26, 2017 This 20-Employee Kendall Square Biotech Just Secured a Seat on Upcoming Space Rocket February 8, 2017 Germany's Fresenius Kabi AG Slams Down $4.3 Billion for Akorn in U.S. Expansion April 24, 2017
This 20-Employee Kendall Square Biotech Just Secured a Seat on Upcoming Space Rocket February 8, 2017
